HLA
RPID icon

Hamilton Lane Advisors’s Rapid Micro Biosystems RPID Stock Holding History

Hamilton Lane Advisors’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-97,916
Closed -$421K – 73
2022
Q2 		$421K Buy
+97,916
New +$456K 0.16% 49

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Hamilton Lane Advisors's RPID Position: Q3 2022 in Review

Hamilton Lane Advisors sold out of Rapid Micro Biosystems (RPID) in Q3 2022, closing a stake of 97,916 shares — an estimated $421K sold.

Hamilton Lane Advisors first reported a position in RPID in Q2 2022 and held it in 1 quarter. The position peaked at $421K in Q2 2022. 53 funds tracked by Wall St. Rank hold RPID as of Q3 2022.

  • Hamilton Lane Advisors reported no remaining Rapid Micro Biosystems position as of Q3 2022 after selling out during the quarter.
  • Hamilton Lane Advisors sold 97,916 Rapid Micro Biosystems shares in Q3 2022, an estimated $421K.
  • Hamilton Lane Advisors first reported a position in Rapid Micro Biosystems in Q2 2022 and held it in 1 quarter.
  • Hamilton Lane Advisors's Rapid Micro Biosystems position peaked at $421K in Q2 2022.
  • 53 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q3 2022.

Based on Hamilton Lane Advisors's 13F filing for Q3 2022, filed 8 Nov 2022.